计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab095464-10μg |
10μg |
现货 ![]() |
| |
| Ab095464-50μg |
50μg |
现货 ![]() |
| |
| Ab095464-100μg |
100μg |
现货 ![]() |
| |
| Ab095464-1mg |
1mg |
期货 ![]() |
|
| 产品名称 | CD86 Mouse mAb |
|---|---|
| 别名 | CD86小鼠单克隆抗体 | CD86小鼠单抗 |
| 英文别名 | Activation B7-2 antigen | B70 | BU63 | CTLA-4 counter-receptor B7.2 | FUN-1 |
| 规格或纯度 | 无载体, ExactAb™, 无叠氮钠, 已验证, 见COA |
| 宿主种属 | 小鼠(Mouse) |
| 特异性 | CD86 |
| 种属反应性 | 人(Human) |
| 免疫原 | ARH 77 (B lymphoblastoid cell line). |
| 阳性对照 | Flow: Human peripheral blood monocyte. |
| 偶联 | Unconjugated |
| 克隆类型 | 单克隆抗体 |
|---|---|
| 克隆号 | BU63 |
| Format | Whole IgG |
| 亚型 | Mouse IgG1 |
| SDS-PAGE | 150 kDa |
| 纯化方法 | Protein G purified |
| 物理外观 | Liquid |
| 储存缓冲液 | 10mM PBS, 0.1% Proclin 300, pH 7.2-7.4 |
| 防腐剂 | 0.1% Proclin 300 |
| 浓度 | 见COA |
| 储存温度 | 2-8°C储存 |
| 运输条件 | 冰袋运输 |
| 稳定性与储存 | 4°C 下运输。4°C 长期保存(12 个月)。收货后建议分装。 |
| 分子类型 | 抗体 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
Anti-CD86 antibody (Ab095464) - Flow Cytometry
Flow Cytometry analysis of Raji cells labelling CD86 (red) with Anti-CD86 antibody (Ab095464) at 0.1 μg/mL for 1 hour at 4°C. AffiniPure Goat anti-Mouse IgG, Fcγ fragment specific (AF647) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, mouse IgG (Ab170221). Black - Unlabelled control, cells without incubation with primary antibody.
| 应用名称 | 稀释比例 |
|---|---|
| Flow Cytometry | 1μg/100w cells |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Ab095464 | |
| 分析证书 | Ab095464 | |
| 分析证书 | Ab095464 |
¥319.92
¥399.92
¥319.92
¥319.92
| 1. Vicente Rabaneda EF, Herrero-Beaumont G, Castañeda S. (2013) Update on the use of abatacept for the treatment of rheumatoid arthritis.. Expert Rev Clin Immunol, 9 (7): (599-621). [PMID:23899231] |
| 2. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. (1991) CTLA-4 is a second receptor for the B cell activation antigen B7.. J Exp Med, 174 (3): (561-9). [PMID:1714933] |
| 3. Engel, P P and 8 more authors.. (1994) The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen.. Blood, (1): [PMID:7520767] |
| 4. Lanier, L L LL and 7 more authors.. (1995) CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.. Journal of immunology (Baltimore, Md. : 1950), (1): [PMID:7527824] |
| 5. Jellis, C L CL and 6 more authors.. (1995) Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86).. Immunogenetics, [PMID:7541777] |
| 6. Azuma, M M and 6 more authors.. (1993) B70 antigen is a second ligand for CTLA-4 and CD28.. Nature, (4): [PMID:7694153] |
| 7. Freeman, G J GJ and 7 more authors.. (1993) Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.. Science (New York, N.Y.), (5): [PMID:7694363] |
| 8. Magistrelli, G G and 5 more authors.. (2001) Identification of an alternatively spliced variant of human CD86 mRNA.. Biochemical and biophysical research communications, (9): [PMID:11162656] |
| 9. Schwartz, J C JC, Zhang, X X, Fedorov, A A AA, Nathenson, S G SG and Almo, S C SC.. (2001) Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.. Nature, (29): [PMID:11279501] |
| 10. Chen, X X, Ji, Z L ZL and Chen, Y Z YZ.. (2002) TTD: Therapeutic Target Database.. Nucleic acids research, (1): [PMID:11752352] |
| 11. Goto, Eiji E and 6 more authors.. (2003) c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity.. The Journal of biological chemistry, (25): [PMID:12582153] |
| 12. Zhang, Xuewu X, Schwartz, Jean-Claude D JC, Almo, Steven C SC and Nathenson, Stanley G SG.. (2003) Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signaling.. Proceedings of the National Academy of Sciences of the United States of America, (4): [PMID:12606712] |
| 13. and Kremer, Joel M JM.. (2005) Selective costimulation modulators: a novel approach for the treatment of rheumatoid arthritis.. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, [PMID:16357751] |
| 14. Hervey, Pauline S PS and Keam, Susan J SJ.. (2006) Abatacept.. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, [PMID:16573350] |
| 15. Muzny, Donna M DM and 113 more authors.. (2006) The DNA sequence, annotation and analysis of human chromosome 3.. Nature, (27): [PMID:16641997] |
| 16. Weyand, Cornelia M CM and Goronzy, Jörg J JJ.. (2006) T-cell-targeted therapies in rheumatoid arthritis.. Nature clinical practice. Rheumatology, [PMID:16932686] |
| 17. and Scheinfeld, Noah N.. (2006) Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists.. The Journal of dermatological treatment, [PMID:16971318] |
| 18. Vincenti, Flavio F and Luggen, Michael M.. (2007) T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation.. Annual review of medicine, [PMID:17020493] |
| 19. Nogid, Anna A and Pham, David Q DQ.. (2006) Role of abatacept in the management of rheumatoid arthritis.. Clinical therapeutics, [PMID:17212998] |
| 20. Reynolds, Jennifer J, Shojania, Kam K and Marra, Carlo A CA.. (2007) Abatacept: a novel treatment for moderate-to-severe rheumatoid arthritis.. Pharmacotherapy, [PMID:18041889] |
| 21. and Vincenti, Flavio F.. (2008) Costimulation blockade in autoimmunity and transplantation.. The Journal of allergy and clinical immunology, [PMID:18269922] |
| 22. Maxwell, Lara J LJ and Singh, Jasvinder A JA.. (2010) Abatacept for rheumatoid arthritis: a Cochrane systematic review.. The Journal of rheumatology, [PMID:20080922] |
| 23. Kleinpeter, Patricia and 20 more authors.. (2019) By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.. Journal of virology, (1): [PMID:30918073] |